Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Conflict of interest: will it ever end?

Carney SL.

Intern Med J. 2012 Nov;42(11):1255-6. doi: 10.1111/j.1445-5994.2012.02940.x.

PMID:
23157520
2.

The statin wars.

McKillop T.

Lancet. 2003 Nov 1;362(9394):1498. No abstract available.

PMID:
14602449
3.

The stain wars.

Olsson GO, Blasetto JW, Bryzinski BS, Caplan RJ, Gold A.

Lancet. 2003 Nov 29;362(9398):1855-6; discussion 1856. No abstract available.

PMID:
14654329
4.

Public health. U.S. panel favors wider use of preventive drug treatment.

Couzin-Frankel J.

Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130. No abstract available.

PMID:
20056859
5.

The stain wars.

Jureidini J, Mansfield P, Menkes D.

Lancet. 2003 Nov 29;362(9398):1855; discussion 1856. No abstract available.

PMID:
14654332
6.

Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.

[No authors listed]

Cardiovasc J Afr. 2008 Nov-Dec;19(6):332-4, discussion 335. No abstract available.

7.

The numbers are in: statins for the primary prevention of cardiovascular disease in women.

Duvernoy CS, Blumenthal R.

Circulation. 2010 Mar 9;121(9):1063-5. doi: 10.1161/CIR.0b013e3181d731c6. Epub 2010 Feb 22. No abstract available.

8.

Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.

[No authors listed]

Cardiovasc J Afr. 2008 Mar-Apr;19(2):117. No abstract available.

9.

Cardiovascular risk in uremic patients: darkness after AURORA.

Robles NR, Macias JF.

Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652. Review. No abstract available.

PMID:
20199190
10.

Rosuvastatin in patients with elevated C-reactive protein.

Mak KH, Chan ES.

N Engl J Med. 2009 Mar 5;360(10):1039-40; author reply 1041-2. No abstract available.

PMID:
19271274
11.

The stain wars.

Wozniak P.

Lancet. 2003 Nov 29;362(9398):1855; discussion 1856. No abstract available.

PMID:
14654331
12.

[By JUPITER! Disease mongering!].

Welin L, Peterson M.

Lakartidningen. 2008 Dec 17;105(51-52):3756; discussion 3756-7. Swedish. No abstract available.

PMID:
19278103
13.

Industry and the academy: conflicts of interest in contemporary health research.

Downie J, Baird P, Thompson J.

Health Law J. 2002;10:103-22. No abstract available.

PMID:
14748274
14.
15.

Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.

[No authors listed]

Ann Intern Med. 2010 Apr 20;152(8):I34. doi: 10.7326/0003-4819-152-8-201004200-00002. No abstract available.

PMID:
20404365
16.

[Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].

Angermann CE, Nitschmann S.

Internist (Berl). 2008 Jul;49(7):884-6. doi: 10.1007/s00108-008-2124-x. German. No abstract available.

PMID:
18427760
17.

New drug to lower cholesterol.

[No authors listed]

FDA Consum. 2003 Nov-Dec;37(6):3. No abstract available.

18.

Efficacy and safety of rosuvastatin in the management of dyslipidemia.

Rubba P, Marotta G, Gentile M.

Vasc Health Risk Manag. 2009;5(1):343-52. Epub 2009 Apr 8. Review.

19.

[Rosuvastatin in patients with chronic heart failure].

Hoppe UC, Nitschmann S.

Internist (Berl). 2009 Apr;50(4):501-2. doi: 10.1007/s00108-009-2360-8. German. No abstract available.

PMID:
19300974
20.

[Statin cuts cardiovascular risk in half].

Einecke D.

MMW Fortschr Med. 2008 Dec 4;150(49-50):12-3. German. No abstract available.

PMID:
19133364

Supplemental Content

Support Center